Want to join the conversation?
During 1Q17, $SCHL's corporate overhead was $26.4MM vs. $16.5MM in 1Q16, which included one-time items of $1.4MM. The increase in overhead is related to higher medical claims, previously announced wage improvement, facility-related expenses, and investments in strategic technology platforms and solutions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?